116 related articles for article (PubMed ID: 15361643)
1. Cancer and leukemia group B (CALGB) 89805: phase II chemoradiation trial using gemcitabine in patients with locoregional adenocarcinoma of the pancreas.
Blackstock AW; Tepper JE; Niedwiecki D; Hollis DR; Mayer RJ; Tempero MA
Int J Gastrointest Cancer; 2003; 34(2-3):107-16. PubMed ID: 15361643
[TBL] [Abstract][Full Text] [Related]
2. A phase 2 trial of gemcitabine, 5-fluorouracil, and radiation therapy in locally advanced nonmetastatic pancreatic adenocarcinoma : cancer and Leukemia Group B (CALGB) 80003.
Mamon HJ; Niedzwiecki D; Hollis D; Tan BR; Mayer RJ; Tepper JE; Goldberg RM; Blackstock AW; Fuchs CS;
Cancer; 2011 Jun; 117(12):2620-8. PubMed ID: 21656739
[TBL] [Abstract][Full Text] [Related]
3. A phase I study evaluating the role of the anti-epidermal growth factor receptor (EGFR) antibody cetuximab as a radiosensitizer with chemoradiation for locally advanced pancreatic cancer.
Arnoletti JP; Frolov A; Eloubeidi M; Keene K; Posey J; Wood T; Greeno E; Jhala N; Varadarajulu S; Russo S; Christein J; Oster R; Buchsbaum DJ; Vickers SM
Cancer Chemother Pharmacol; 2011 Apr; 67(4):891-7. PubMed ID: 20589377
[TBL] [Abstract][Full Text] [Related]
4. Gemcitabine therapy in patients with advanced pancreatic cancer.
Min YJ; Joo KR; Park NH; Yun TK; Nah YW; Nam CW; Park JH
Korean J Intern Med; 2002 Dec; 17(4):259-62. PubMed ID: 12647642
[TBL] [Abstract][Full Text] [Related]
5. Effect of gemcitabine on immune cells in subjects with adenocarcinoma of the pancreas.
Plate JM; Plate AE; Shott S; Bograd S; Harris JE
Cancer Immunol Immunother; 2005 Sep; 54(9):915-25. PubMed ID: 15782312
[TBL] [Abstract][Full Text] [Related]
6. Weekly paclitaxel, gemcitabine, and external irradiation followed by randomized farnesyl transferase inhibitor R115777 for locally advanced pancreatic cancer.
Rich TA; Winter K; Safran H; Hoffman JP; Erickson B; Anne PR; Myerson RJ; Cline-Burkhardt VJ; Perez K; Willett C
Onco Targets Ther; 2012; 5():161-70. PubMed ID: 22977306
[TBL] [Abstract][Full Text] [Related]
7. Induction chemotherapy selects patients with locally advanced, unresectable pancreatic cancer for optimal benefit from consolidative chemoradiation therapy.
Krishnan S; Rana V; Janjan NA; Varadhachary GR; Abbruzzese JL; Das P; Delclos ME; Gould MS; Evans DB; Wolff RA; Crane CH
Cancer; 2007 Jul; 110(1):47-55. PubMed ID: 17538975
[TBL] [Abstract][Full Text] [Related]
8. Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an Eastern Cooperative Oncology Group trial.
Loehrer PJ; Feng Y; Cardenes H; Wagner L; Brell JM; Cella D; Flynn P; Ramanathan RK; Crane CH; Alberts SR; Benson AB
J Clin Oncol; 2011 Nov; 29(31):4105-12. PubMed ID: 21969502
[TBL] [Abstract][Full Text] [Related]
9. Chemoradiotherapy in the management of locally advanced pancreatic carcinoma: a qualitative systematic review.
Huguet F; Girard N; Guerche CS; Hennequin C; Mornex F; Azria D
J Clin Oncol; 2009 May; 27(13):2269-77. PubMed ID: 19307501
[TBL] [Abstract][Full Text] [Related]
10. New developments in the treatment of pancreatic cancer. Highlights from the "44th ASCO Annual Meeting". Chicago, IL, USA. May 30 - June 3, 2008.
Saif MW
JOP; 2008 Jul; 9(4):391-7. PubMed ID: 18648128
[TBL] [Abstract][Full Text] [Related]
11. Preliminary Investigation of the Efficacy and Indications of Proton Beam Therapy for Stage IV Pancreatic Adenocarcinoma.
Yamaguchi H; Kato T; Narita Y; Honda M; Hamada K; Ishikawa Y; Seto I; Takagawa Y; Kikuchi Y; Murakami M
Cureus; 2024 Apr; 16(4):e57771. PubMed ID: 38716033
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic Cancer: Feasibility and Outcome After Radiochemotherapy with High Dose External Radiotherapy for Non-resected and R1 Resected Patients.
Lauffer DC; Kuhn PA; Kueng M; Thalmann SU; Risse G; Tercier PA; Egger B; Allal AS
Cureus; 2018 May; 10(5):e2713. PubMed ID: 30079279
[TBL] [Abstract][Full Text] [Related]
13. Hypofractionated Conformal Radiotherapy with Concurrent Full-Dose Gemcitabine Versus Standard Fractionation Radiotherapy with Concurrent Fluorouracil for Unresectable Pancreatic Cancer: a Multi-Institution Experience.
Rakhra S; Strauss JB; Robertson J; McGinn CJ; Kim T; Huang J; Blake A; Helenowski I; Hayes JP; Mulcahy M; Small W
J Gastrointest Cancer; 2016 Jun; 47(2):196-201. PubMed ID: 27112332
[TBL] [Abstract][Full Text] [Related]
14. Contemporary Management of Borderline Resectable and Locally Advanced Unresectable Pancreatic Cancer.
Shaib WL; Ip A; Cardona K; Alese OB; Maithel SK; Kooby D; Landry J; El-Rayes BF
Oncologist; 2016 Feb; 21(2):178-87. PubMed ID: 26834159
[TBL] [Abstract][Full Text] [Related]
15. Concurrent radiotherapy with oral fluoropyrimidine versus gemcitabine in locally advanced pancreatic cancer: a systematic review and meta-analysis.
Yang YF; Cao XH; Bao CE; Wan X
Onco Targets Ther; 2015; 8():3315-22. PubMed ID: 26635481
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors and sites of metastasis in unresectable locally advanced pancreatic cancer.
Peixoto RD; Speers C; McGahan CE; Renouf DJ; Schaeffer DF; Kennecke HF
Cancer Med; 2015 Aug; 4(8):1171-7. PubMed ID: 25891650
[TBL] [Abstract][Full Text] [Related]
17. Elevated serum CA72-4 levels predict poor prognosis in pancreatic adenocarcinoma after intensity-modulated radiation therapy.
Liu P; Zhu Y; Liu L
Oncotarget; 2015 Apr; 6(11):9592-9. PubMed ID: 25860937
[TBL] [Abstract][Full Text] [Related]
18. Maintenance therapy with capecitabine in patients with locally advanced unresectable pancreatic adenocarcinoma.
Saif MW; Ledbetter L; Kaley K; Garcon MC; Rodriguez T; Syrigos KN
Oncol Lett; 2014 Sep; 8(3):1302-1306. PubMed ID: 25120712
[TBL] [Abstract][Full Text] [Related]
19. The inhibitory effect of heat treatment against epithelial-mesenchymal transition (EMT) in human pancreatic adenocarcinoma cell lines.
Kimura-Tsuchiya R; Ishikawa T; Kokura S; Mizushima K; Adachi S; Okajima M; Matsuyama T; Okayama T; Sakamoto N; Katada K; Kamada K; Uchiyama K; Handa O; Takagi T; Yagi N; Naito Y; Itoh Y
J Clin Biochem Nutr; 2014 Jul; 55(1):56-61. PubMed ID: 25120280
[TBL] [Abstract][Full Text] [Related]
20. A Phase II Trial of Cetuximab, Gemcitabine, 5-Fluorouracil, and Radiation Therapy in Locally Advanced Nonmetastatic Pancreatic Adenocarcinoma.
Cetin V; Piperdi B; Bathini V; Walsh WV; Yunus S; Tseng JF; Whalen GF; Wassef WY; Kadish SP; Fitzgerald TJ; Mikule C; Wang Y; Grossman SR
Gastrointest Cancer Res; 2013 Jul; 6(4 Suppl 1):S2-9. PubMed ID: 24312684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
